Clinical Trials Logo
  1. Home
  2. Healthy Volunteers
  3. NCT05230862
  4. Details
NCT05230862 Clinical Trial

Does a Multi-ingredient Pre-workout Supplement Enhance Cycling Time Trial Performance?

Healthy Volunteers Clinical Trial

— MIPS  

Official title:
Does a Multi-ingredient Pre-workout Supplement Enhance Cycling Time Trial

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05230862
Other study ID # 2021-M-38
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 2, 2021
Est. completion date September 30, 2022

Study information
Verified date February 2022
Source University of Exeter
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the present study is to test the effect of ingesting a multi-ingredient pre- exercise supplement containing caffeine, creatine, beta-alanine and L-Citrulline compared to a placebo, on endurance exercise performance.

Recruitment information / eligibility
Status Recruiting
Enrollment 15
Est. completion date September 30, 2022
Est. primary completion date August 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Exclusion criteria: - Any diagnosed metabolic health condition - Pregnant - Non-habitual caffeine intake - Smoker - No endurance training - Diagnosed Cardiovascular disease - Recent history of musculoskeletal injury - Anti-depressant and anti-anxiety medication Inclusion criteria - Age 18-40 - Healthy - Highly trained endurance athletes (V?O2max: males >55 and females >50 mL·kg bm-1·min-1) - Both males and females are allowed to participate. If females are on the oral contraceptive pill they are to be tested on consecutive weeks. If they are not on the oral contraceptive pill, then female subjects are to be tested every 4 weeks, at the same point of their menstrual cycle.

Study Design

Related Conditions & MeSH terms

Intervention

Dietary Supplement:
• Ladder Supplement
Caffeine 200mg L-Theanine 200mg L-Citrulline 6g Creatine 5g Beta-Alanine 1.6g Phosphatidylserine 100mg
• Placebo
Placebo

Locations
Country Name City State
United Kingdom School of Sport and Health Sciences Exeter

Sponsors (2)
Lead Sponsor Collaborator
University of Exeter OpenFit LLC

Country where clinical trial is conducted

United Kingdom, 

Outcome
Type Measure Description Time frame Safety issue
Primary Exercise Performance Work done during 15 min time trial (TT) 15 Minitues
Secondary Alertness Visual analog scale 1 Hour
Secondary Motivation Visual analog scale 1 Hour
Secondary Rate of perceived exertion Visual analog scale 1 Hour
Secondary Gas analysis Analysis of expired gas 1 Hour
See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1